Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 18, 2025
Efficacy and safety of switching to long-acting cabotegravir + rilpivirine versus continuing bictegravir/emtricitabine/tenofovir alafenamide in Japanese participants: 12-month results from the phase 3b randomized SOLAR trialEisuke Adachi, Yoshiyuki Yokomaku, Dai Watanabe, et al.
HIV Medicine|December 26, 2023
Asian participants' experience in phase 3/3b studies of long-acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96Shinichi Oka, Vicki Holohan, Takuma Shirasaka, et al.
Open Forum Infectious Diseases|June 17, 2024
Cabotegravir + Rilpivirine Long-Acting: Overview of Injection Guidance, Injection Site Reactions, and Best Practices for Intramuscular Injection AdministrationPaula Teichner, Nadine Chamay, Emilie Elliot, et al.
Pageof 1